AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Marrone Bio InnovationsCalyxtCVR PartnersWynnstay GroupArcadia Biosciences
SymbolNASDAQ:MBIINASDAQ:CLXTNYSE:UANLON:WYNNASDAQ:RKDA
Price Information
Current Price$1.07$4.63$0.82GBX 302.50$3.73
52 Week RangeBuyHoldHoldBuyBuy
Beat the Market™ Rank
Overall Score1.31.71.31.31.3
Analysis Score3.53.13.00.03.5
Community Score2.32.52.02.32.6
Dividend Score0.00.00.02.50.0
Ownership Score0.03.01.00.00.0
Earnings & Valuation Score0.60.00.61.90.6
Analyst Ratings
Consensus RecommendationBuyHoldHoldBuyBuy
Consensus Price Target$1.88$7.00$3.00N/A$15.00
% Upside from Price Target76.01% upside51.19% upside265.32% upsideN/A302.14% upside
Trade Information
Market Cap$154.26 million$152.98 million$102.67 million£59.02 million$38.28 million
Beta0.282.411.36N/A-0.81
Average Volume226,361106,226223,07817,397232,691
Sales & Book Value
Annual Revenue$29.37 million$7.30 million$404.18 million£459.32 million$1.17 million
Price / Sales5.3020.960.230.1332.03
CashflowN/AN/A$0.39 per shareGBX 17.30 per shareN/A
Price / CashN/AN/A2.1217.49N/A
Book Value$0.18 per share$1.90 per share$3.70 per shareGBX 484.40 per share$0.96 per share
Price / Book5.942.440.220.013.89
Profitability
Net Income$-37,170,000.00$-39,610,000.00$-34,970,000.00N/A$-28,810,000.00
EPS($0.21)($1.21)N/AGBX 31.40($3.37)
Trailing P/E RatioN/AN/AN/A9.63N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-132.76%-455.07%-12.81%N/A-1,035.38%
Return on Equity (ROE)-136.82%-64.78%-11.27%N/A-180.70%
Return on Assets (ROA)-37.67%-47.52%-4.28%N/A-61.05%
Dividend
Annual PayoutN/AN/AN/AGBX 14N/A
Dividend YieldN/AN/AN/A4.63%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A44.59%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.91%0.35%1.59%12.82%0.45%
Current Ratio1.05%9.38%1.44%1.76%4.09%
Quick Ratio0.80%8.80%0.84%1.10%3.06%
Ownership Information
Institutional Ownership Percentage34.95%23.93%36.86%N/A5.07%
Insider Ownership Percentage3.40%2.30%N/AN/A3.50%
Miscellaneous
Employees1135029093044
Shares Outstanding145.53 million33.04 million113.28 million20.01 million10.05 million
Next Earnings Date8/13/2020 (Estimated)8/4/2020 (Estimated)7/22/2020 (Estimated)N/A8/12/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.